ホーム › 乳がん › ミシガン州 › Grand Rapids

Grand Rapids、MIにおける乳がんの臨床試験

Grand Rapidsとその周辺地域（約30マイル以内）の拠点で、乳がんに関する26件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト（英語）

ここで研究参加者を募集していますか？このページの上部に表示できます — 30日間 $99 →

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

被験者募集中第1相

START - Midwest, Grand Rapids

18歳以上 · 全性別 · 2026/10/05更新 · NCT06784193

A Study of PHST001 in Advanced Solid Tumors

被験者募集中第1相

START Center for Cancer Research - Midwest, Grand Rapids

18歳以上 · 全性別 · 2026/10/05更新 · NCT06840886

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

被験者募集中観察研究健康なボランティア歓迎

Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids

40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

被験者募集中

Cancer & Hematology Centers, Grand Rapids

18歳以上 · 全性別 · 2026/09/23更新 · NCT07214532

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

被験者募集中第1相

BAMF Health Inc., Grand Rapids

18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

被験者募集中第1相

BAMF Health Inc., Grand Rapids

18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

被験者募集中第1/2相

START Midwest, LLC, Grand Rapids

18歳以上 · 全性別 · 2026/09/17更新 · NCT06827236

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

被験者募集中第3相

The Cancer & Hematology Centers, Grand Rapids

18歳以上 · 全性別 · 2026/09/15更新 · NCT06492616

A Phase 1/1b Study of IAM1363 in HER2 Cancers

被験者募集中第1相

START - Midwest Cancer Research Center, Grand Rapids

18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

被験者募集中第1相

South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids

18歳以上 · 全性別 · 2026/09/04更新 · NCT06400472

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

被験者募集中第3相

Cancer & Hematology Centers of Western Michigan, Grand Rapids

18歳以上 · 全性別 · 2026/09/03更新 · NCT06790693

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

被験者募集中第3相

Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids

18歳〜60歳 · 女性 · 2026/09/02更新 · NCT05879926

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

被験者募集中第1相

South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids

18歳以上 · 全性別 · 2026/08/28更新 · NCT07029399

A Study of MGC026 in Participants With Advanced Solid Tumors

被験者募集中第1相

START Midwest, Grand Rapids

18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470

E-Mindfulness Approaches for Living After Breast Cancer

被験者募集中第3相

Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids

18歳〜50歳 · 全性別 · 2026/08/04更新 · NCT06748222

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

被験者募集中第1/2相

START Midwest, Grand Rapids

18歳以上 · 全性別 · 2026/08/04更新 · NCT05579366

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

被験者募集中第1相

BAMF Health, Grand Rapids

18歳〜100歳 · 全性別 · 2026/07/29更新 · NCT06562192

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

被験者募集中第1相

START Midwest, LLC, Grand Rapids

18歳以上 · 全性別 · 2026/07/22更新 · NCT07318805

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

被験者募集中第1/2相

START Midwest, Grand Rapids

18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

被験者募集中第2相

GSK Investigational Site, Grand Rapids

18歳以上 · 全性別 · 2026/06/24更新 · NCT04641247

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

被験者募集中第3相

Cancer and Hematology Centers of Western Michigan, Grand Rapids

18歳以上 · 全性別 · 2026/06/22更新 · NCT05696626

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

被験者募集中第3相

Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Trinity Health Grand Rapids Hospital, Grand Rapids

50歳〜70歳 · 全性別 · 2026/04/23更新 · NCT04852887